Business Description
Toleranzia AB
ISIN : SE0007438577
Compare
Compare
Traded in other countries / regions
TOL.Sweden0EH.Germany IPO Date
2020-12-14Description
Toleranzia AB is a pharmaceutical company based in Sweden. The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 21.53 | |||||
| Equity-to-Asset | 0.96 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.12 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 25.6 | |||||
| 3-Year EPS without NRI Growth Rate | 25 | |||||
| 3-Year FCF Growth Rate | -0.5 | |||||
| 3-Year Book Growth Rate | -14.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.07 | |||||
| 9-Day RSI | 37.38 | |||||
| 14-Day RSI | 42.62 | |||||
| 6-1 Month Momentum % | 21.28 | |||||
| 12-1 Month Momentum % | -60.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.24 | |||||
| Quick Ratio | 3.24 | |||||
| Cash Ratio | 3.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -53.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -5.64 | |||||
| ROA % | -5.37 | |||||
| ROIC % | -7 | |||||
| ROC (Joel Greenblatt) % | -9418.16 | |||||
| ROCE % | -5.53 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.69 | |||||
| EV-to-EBIT | -12.03 | |||||
| EV-to-Forward-EBIT | 0.99 | |||||
| EV-to-EBITDA | -12.07 | |||||
| EV-to-Forward-Revenue | 0.47 | |||||
| EV-to-FCF | -1.55 | |||||
| Earnings Yield (Greenblatt) % | -8.31 | |||||
| FCF Yield % | -53.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Toleranzia AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.006 | ||
| Beta | 1.96 | ||
| Volatility % | 158.31 | ||
| 14-Day RSI | 42.62 | ||
| 14-Day ATR (€) | 0.003192 | ||
| 20-Day SMA (€) | 0.02664 | ||
| 12-1 Month Momentum % | -60.96 | ||
| 52-Week Range (€) | 0.0108 - 0.0626 | ||
| Shares Outstanding (Mil) | 197.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Toleranzia AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Toleranzia AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Toleranzia AB Frequently Asked Questions
What is Toleranzia AB(FRA:0EH)'s stock price today?
The current price of FRA:0EH is €0.02. The 52 week high of FRA:0EH is €0.06 and 52 week low is €0.01.
When is next earnings date of Toleranzia AB(FRA:0EH)?
The next earnings date of Toleranzia AB(FRA:0EH) is 2024-05-20.
Does Toleranzia AB(FRA:0EH) pay dividends? If so, how much?
Toleranzia AB(FRA:0EH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers